Parameter | Total (N = 603) |
Gender, n (% male) | 338 (56.1%) |
Age, year | 65.75 ± 11.02 |
Smoking, n (%) | 148 (24.5%) |
Drinking, n (%) | 62 (10.3%) |
Past history: | |
Hypertension, n (%) | 403 (66.8%) |
Diabetes, n (%) | 120 (19.9%) |
Hyperlipidemia, n (%) | 59 (9.8%) |
Stroke, n (%) | 119 (19.7%) |
Renal insufficiency, n (%) | 7 (1.2%) |
Peptic injury, n (%) | 64 (10.6%) |
Combined medication: | |
PPI (%) | 404 (67.0%) |
Heparin sodium, n (%) | 250 (41.5%) |
Dabigatran, n (%) | 6 (1.0%) |
Warfarin, n (%) | 21 (3.5%) |
Ticagrelor, n (%) | 33 (5.5%) |
β-blocker, n (%) | 421 (69.8%) |
CCB, n (%) | 265 (43.9%) |
ACEI, n (%) | 110 (18.2%) |
ARB, n (%) | 197 (32.7%) |
Diuretics, n (%) | 82 (13.6%) |
Antidiabetics, n (%) | 71 (11.8%) |
Digoxin, n (%) | 14 (2.3%) |
Amiodarone, n (%) | 14 (2.3%) |